141 related articles for article (PubMed ID: 35341001)
1. In Silico Analysis Identifies Upregulated lncRNA DLGAP1-AS1 Which Is Correlated to Poor Prognosis and Promotes Cell Proliferation in Glioblastoma.
Huang Y; Liu L; Fang M; Yan W
Comput Math Methods Med; 2022; 2022():5038124. PubMed ID: 35341001
[TBL] [Abstract][Full Text] [Related]
2. LncRNA DLGAP1-AS1 accelerates glioblastoma cell proliferation through targeting miR-515-5p/ROCK1/NFE2L1 axis and activating Wnt signaling pathway.
Wang Z; Han Y; Li Q; Wang B; Ma J
Brain Behav; 2021 Oct; 11(10):e2321. PubMed ID: 34536977
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA DLGAP1-AS1 promotes the progression of glioma by regulating the miR-1297/EZH2 axis.
Liu L; Li X; Shi Y; Chen H
Aging (Albany NY); 2021 Apr; 13(8):12129-12142. PubMed ID: 33901010
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA DLGAP1 antisense RNA 1 accelerates glioma progression via the microRNA-628-5p/DEAD-box helicase 59 pathway.
Hu KQ; Ao XS
Clinics (Sao Paulo); 2022; 77():100002. PubMed ID: 35113786
[TBL] [Abstract][Full Text] [Related]
5. Novel LncRNA OXCT1-AS1 indicates poor prognosis and contributes to tumorigenesis by regulating miR-195/CDC25A axis in glioblastoma.
Zhong C; Yu Q; Peng Y; Zhou S; Liu Z; Deng Y; Guo L; Zhao S; Chen G
J Exp Clin Cancer Res; 2021 Apr; 40(1):123. PubMed ID: 33832517
[TBL] [Abstract][Full Text] [Related]
6. Long Non-coding RNA DLGAP1-AS1 and DLGAP1-AS2: Two Novel Oncogenes in Multiple Cancers.
Zhao F; Tan F; Tang L; Du Z; Chen X; Yang Y; Zhou G; Yuan C
Curr Med Chem; 2023; 30(25):2822-2834. PubMed ID: 36121088
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA DLGAP1-AS1 facilitates tumorigenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via the feedback loop of miR-26a/b-5p/IL-6/JAK2/STAT3 and Wnt/β-catenin pathway.
Lin Y; Jian Z; Jin H; Wei X; Zou X; Guan R; Huang J
Cell Death Dis; 2020 Jan; 11(1):34. PubMed ID: 31949128
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA DLGAP1-AS1 promotes cell proliferation in hepatocellular carcinoma via sequestering miR-486-5p.
Peng X; Wei F; Hu X
J Cell Biochem; 2020 Feb; 121(2):1953-1962. PubMed ID: 31633236
[TBL] [Abstract][Full Text] [Related]
9. The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells.
Mazor G; Levin L; Picard D; Ahmadov U; Carén H; Borkhardt A; Reifenberger G; Leprivier G; Remke M; Rotblat B
Cell Death Dis; 2019 Mar; 10(3):246. PubMed ID: 30867410
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA FOXD2-AS1 promotes glioma cell cycle progression and proliferation through the FOXD2-AS1/miR-31/CDK1 pathway.
Wang J; Li B; Wang C; Luo Y; Zhao M; Chen P
J Cell Biochem; 2019 Dec; 120(12):19784-19795. PubMed ID: 31347720
[TBL] [Abstract][Full Text] [Related]
11. LncRNA IDH1-AS1 suppresses cell proliferation and tumor growth in glioma.
Wang J; Quan Y; Lv J; Dong Q; Gong S
Biochem Cell Biol; 2020 Oct; 98(5):556-564. PubMed ID: 32990028
[TBL] [Abstract][Full Text] [Related]
12. LncRNA SOCS2-AS1 promotes the progression of glioma via regulating ITGB1 expression.
Wu D; Sun J; Wang H; Ma C
Neurosci Lett; 2021 Nov; 765():136248. PubMed ID: 34536509
[TBL] [Abstract][Full Text] [Related]
13. AGAP2-AS1 serves as an oncogenic lncRNA and prognostic biomarker in glioblastoma multiforme.
Tian Y; Zheng Y; Dong X
J Cell Biochem; 2019 Jun; 120(6):9056-9062. PubMed ID: 30525219
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1.
Luo W; Li X; Song Z; Zhu X; Zhao S
Aging (Albany NY); 2019 Jun; 11(11):3811-3823. PubMed ID: 31186379
[TBL] [Abstract][Full Text] [Related]
15. LncRNA DLGAP1-AS2 modulates glioma development by up-regulating YAP1 expression.
Miao W; Li N; Gu B; Yi G; Su Z; Cheng H
J Biochem; 2020 Apr; 167(4):411-418. PubMed ID: 31899508
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of DLGAP1-Antisense RNA 1 Alleviates Vascular Endothelial Cell Injury Via Activation of the Phosphoinositide 3-kinase/Akt Pathway Results from an Acute Limb Ischemia Rat Model.
Shen GH; Song Y; Yao Y; Sun QF; Jing B; Wu J; Li SY; Liu SQ; Li HC; Yuan C; Liu GY; Li JB; Liu XY; Wang HY
Eur J Vasc Endovasc Surg; 2020 Jan; 59(1):98-107. PubMed ID: 31744785
[TBL] [Abstract][Full Text] [Related]
17. Data mining of bulk and single-cell RNA sequencing introduces OBI1-AS1 as an astrocyte marker with possible role in glioma recurrence and progression.
Mamivand A; Bayat S; Maghrouni A; Shabani S; Khoshnevisan A; Saffar H; Tabrizi M
Clin Epigenetics; 2022 Mar; 14(1):35. PubMed ID: 35260196
[TBL] [Abstract][Full Text] [Related]
18. Expression of lncRNAs in Low-Grade Gliomas and Glioblastoma Multiforme: An In Silico Analysis.
Reon BJ; Anaya J; Zhang Y; Mandell J; Purow B; Abounader R; Dutta A
PLoS Med; 2016 Dec; 13(12):e1002192. PubMed ID: 27923049
[TBL] [Abstract][Full Text] [Related]
19. USP30-AS1 contributes to mitochondrial quality control in glioblastoma cells.
Wang N; Li J; Xin Q; Xu N
Biochem Biophys Res Commun; 2021 Dec; 581():31-37. PubMed ID: 34653676
[TBL] [Abstract][Full Text] [Related]
20. lncRNA MNX1-AS1 Promotes Glioblastoma Progression Through Inhibition of miR-4443.
Gao Y; Xu Y; Wang J; Yang X; Wen L; Feng J
Oncol Res; 2019 Feb; 27(3):341-347. PubMed ID: 29678219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
